Argos Therapeutics' Grant - III Round

Argos Therapeutics raised a round of funding on October 14, 2010. Investors include Qualifying Therapeutic Discovery Project.

Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…

Articles about Argos Therapeutics' Grant - III Round: